Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

BACKGROUND: Renal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Hideki, Nangaku, Masaomi, Hirakata, Hideki, Wada, Takashi, Hayashi, Terumasa, Sato, Hiroshi, Yamazaki, Yasushi, Masaki, Takao, Kagimura, Tatsuo, Yamamoto, Hiroyasu, Hase, Hiroki, Kamouchi, Masahiro, Imai, Enyu, Mizuno, Kyoichi, Iwasaki, Manabu, Akizawa, Tadao, Tsubakihara, Yoshiharu, Maruyama, Shoichi, Narita, Ichiei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805810/
https://www.ncbi.nlm.nih.gov/pubmed/28660446
http://dx.doi.org/10.1007/s10157-017-1427-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805810/
https://www.ncbi.nlm.nih.gov/pubmed/28660446
http://dx.doi.org/10.1007/s10157-017-1427-4

Ejemplares similares